EPO rules on contested gene patent Kathy Redmond 1 May 2005 Senza categoria 0 Number 6 Download pdf article The European Patent Office (EPO) has decided that the European patent on mutations in breast and ovarian cancer susceptibility (EP 705903) is to be maintained in amended form. Download full article cancer drugsEuropean Patent Officegene patents
Spotlight on How much is too much? Will someone please take charge of finding answers? Spotlight on 27 October 2017 0
Senza categoria Health rationing in Europe: can cancer get a fair hearing? Senza categoria 1 May 2009 0
